key: cord-0745373-6ph6f4kp
authors: Miriam Michaelson, Nara; Malhotra, Ashwin; Wang, Zehui; Heier, Linda; Tanji, Kurenai; Wolfe, Scott; Gupta, Alka; MacGowan, Daniel
title: Peripheral neurological complications during COVID-19: A single center experience
date: 2021-12-23
journal: J Neurol Sci
DOI: 10.1016/j.jns.2021.120118
sha: e0c4c532249ba50ed9ba56d2d2d9c352b28d98d9
doc_id: 745373
cord_uid: 6ph6f4kp

BACKGROUND AND AIMS: We highlight the peripheral neurologic complications of coronavirus disease 2019 (COVID-19) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an ongoing global health emergency. METHODS: We evaluated twenty-five patients admitted to the COVID-19 Recovery Unit (CRU) at New York-Presbyterian Weill Cornell University Medical Center after intensive care hospitalization with confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), whom neurology was consulted for weakness and/or paresthesias. All patients were clinically evaluated by a neuromuscular neurologist who performed electrodiagnostic (EDX) studies when indicated. Magnetic resonance imaging (MRI) of the affected regions, along with nerve and muscle biopsies were obtained in select patients to better elucidate the underlying diagnosis. RESULTS: We found fourteen out of twenty-five patients with prolonged hospitalization for COVID-19 infection to have peripheral neurological complications, identified as plexopathies, peripheral neuropathies and entrapment neuropathies. The other eleven patients were not found to have peripheral neurologic causes for their symptoms. Patients with peripheral neurological complications often exhibited more than one type of concurrently. Specifically, there were four cases of plexopathies, nine cases of entrapment neuropathies, and six cases of peripheral neuropathies, which included cranial neuropathy, sciatic neuropathy, and multiple mononeuropathies. CONCLUSIONS: We explore the possibility that the idiopathic peripheral neurologic complications could be manifestations of the COVID-19 disease spectrum, possibly resulting from micro-thrombotic induced nerve ischemia.

1 Abstract:

We highlight the peripheral neurologic complications of coronavirus disease 2019 (COVID-19) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an ongoing global health emergency.

We evaluated twenty-five patients admitted to the COVID-19 Recovery Unit (CRU) at New York-Presbyterian Weill Cornell University Medical Center after intensive care hospitalization with confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), whom neurology was consulted for weakness and/or paresthesias. All patients were clinically evaluated by a neuromuscular neurologist who performed electrodiagnostic (EDX) studies when indicated. Magnetic resonance imaging (MRI) of the affected regions, along with nerve and muscle biopsies were obtained in select patients to better elucidate the underlying diagnosis.

We found fourteen out of twenty-five patients with prolonged hospitalization for COVID-19 infection to have peripheral neurological complications, identified as plexopathies, peripheral neuropathies and entrapment neuropathies. The other eleven patients were not found to have peripheral neurologic causes for their symptoms. Patients with peripheral neurological complications often exhibited more than one type of concurrently. Specifically, there were four cases of plexopathies, nine cases of entrapment neuropathies, and six cases of peripheral neuropathies, which included cranial neuropathy, sciatic neuropathy, and multiple mononeuropathies.

Many neurological complications of the coronavirus disease 2019 (COVID-19) pandemic, such as encephalitis, ischemic stroke, and acute inflammatory demyelinating polyneuropathy (AIDP) have been documented in the literature 1, 2 . However, the full spectrum of peripheral neurological complications of COVID-19 and risk factors have not been well described. Here we present a single center experience as a case series of peripheral neurological complications observed in patients hospitalized with COVID-19.

From March to June of two thousand twenty-one, the neurology service evaluated twenty-five patients admitted to the COVID-19 Recovery Unit (CRU) at New York-Presbyterian Weill Cornell University Medical Center after intensive care hospitalization with confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), whom neurology was consulted for weakness and/or paresthesias. All patients were clinically evaluated by a neuromuscular neurologist who performed electrodiagnostic (EDX) studies when indicated.

Magnetic resonance imaging (MRI) of the affected regions, along with nerve and muscle J o u r n a l P r e -p r o o f 3 biopsies were obtained in select patients to better elucidate the underlying diagnosis. Table 1 describes key demographic patient data, comorbidities, inpatient complications, and relevant peak lab values organized by type of peripheral neurological complication. Table 2 summarizes results EDX studies, MRIs, and muscle and nerve biopsies by peripheral neurologic complication diagnosis. There were ultimately fourteen patients that were found to have peripheral neurological complications from the original twenty-five patients we were asked to evaluate (the remaining eleven were not found to have peripheral causes for their symptoms). 

J o u r n a l P r e -p r o o f

We present the main clinical and laboratory findings of patients with COVID-19 in our single institution who were found to have peripheral neurological complications. We further explore the 11 possibility that these could be manifestations of the COVID-19 disease spectrum, hypothesizing that they could be related to micro-thrombotic induced nerve ischemia.

J o u r n a l P r e -p r o o f n. biopsy: nerve biopsy

Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease

Guillain-Barré Syndrome Associated with SARS-CoV-2

Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease. Cureus

Rhabdomyolysis as Potential Late Complication Associated with COVID-19. Emerg Infect Dis

Upper trunk brachial plexopathy as a consequence of prone positioning due to SARS-CoV-2 acute respiratory distress syndrome. Muscle Nerve

Brachial Plexus Neuropathies During the COVID-19 Pandemic: A Retrospective Case Series

Patients in Critical Care

Unusual Compression Neuropathies of the Forearm, Part I: Radial Nerve. The Journal of Hand Surgery

Anterior Interosseous Nerve and Posterior Interosseous Nerve Involvement in Neuralgic Amyotrophy

Pure Sensory Neuralgic Amyotrophy in COVID-19 Infection

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Common entrapment neuropathies

Neuromuscular disorders in severe acute respiratory syndrome

Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)

Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms

Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink

Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid